Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Sell
2
AIRS Quote, Financials, Valuation and Earnings
Last price:
$1.90
Seasonality move
:
-6.23%
Day range:
$1.79 - $2.06
52-week range:
$1.65 - $9.20
Dividend yield:
0%
P/E ratio:
300.71x
P/S ratio:
0.58x
P/B ratio:
1.33x
Volume:
364.9K
Avg. volume:
341.9K
1-year change:
-67.33%
Market cap:
$105.4M
Revenue:
$180.4M
EPS (TTM):
-$0.15
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AIRS
AirSculpt Technologies
|
$40.3M | -$0.03 | -15.48% | -53.33% | $2.75 |
|
CVS
CVS Health
|
$93.1B | $1.62 | 5.24% | 83.69% | $72.46 |
|
FPCG
First Physicians Capital Group
|
-- | -- | -- | -- | -- |
|
IQV
IQVIA Holdings
|
$3.8B | $2.64 | 1.21% | 69.49% | $242.54 |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- |
|
WORX
SCWorx
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AIRS
AirSculpt Technologies
|
$1.80 | $2.75 | $105.4M | 300.71x | $0.00 | 0% | 0.58x |
|
CVS
CVS Health
|
$67.63 | $72.46 | $85.3B | 18.48x | $0.67 | 3.93% | 0.23x |
|
FPCG
First Physicians Capital Group
|
$1,025.00 | -- | $10M | -- | $0.00 | 0% | 1.40x |
|
IQV
IQVIA Holdings
|
$144.49 | $242.54 | $25.4B | 19.27x | $0.00 | 0% | 1.72x |
|
UNVC
UNIVEC
|
$0.0024 | -- | $434.9K | -- | $0.00 | 0% | -- |
|
WORX
SCWorx
|
$0.80 | -- | $1.7M | -- | $0.00 | 0% | 0.39x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AIRS
AirSculpt Technologies
|
48.51% | 2.888 | 24.66% | 0.39x |
|
CVS
CVS Health
|
46.73% | 1.052 | 116.81% | 0.56x |
|
FPCG
First Physicians Capital Group
|
-- | 0.000 | -- | -- |
|
IQV
IQVIA Holdings
|
69.74% | 0.606 | 40.41% | 0.73x |
|
UNVC
UNIVEC
|
-- | 2.508 | -- | -- |
|
WORX
SCWorx
|
1.08% | 6.895 | 2.61% | 0.31x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AIRS
AirSculpt Technologies
|
$22.4M | -$4.1M | -5.34% | -9.96% | -10.54% | -$815K |
|
CVS
CVS Health
|
$12.9B | $2.5B | 3.29% | 6.12% | 2.95% | $1.1B |
|
FPCG
First Physicians Capital Group
|
-- | -- | -- | -- | -- | -- |
|
IQV
IQVIA Holdings
|
$1.4B | $622M | 6.85% | 21.32% | 18.07% | $721M |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- | -- |
|
WORX
SCWorx
|
$132.6K | -$393.5K | -77.97% | -80.46% | -51.8% | -$362.6K |
AirSculpt Technologies vs. Competitors
-
Which has Higher Returns AIRS or CVS?
CVS Health has a net margin of -12.85% compared to AirSculpt Technologies's net margin of 1.68%. AirSculpt Technologies's return on equity of -9.96% beat CVS Health's return on equity of 6.12%.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies57.25% -$0.09 $154M CVSCVS Health13.2% $1.30 $142B -
What do Analysts Say About AIRS or CVS?
AirSculpt Technologies has a consensus price target of $2.75, signalling upside risk potential of 52.78%. On the other hand CVS Health has an analysts' consensus of $72.46 which suggests that it could grow by 7.14%. Given that AirSculpt Technologies has higher upside potential than CVS Health, analysts believe AirSculpt Technologies is more attractive than CVS Health.
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies0 3 0 CVSCVS Health12 9 0 -
Is AIRS or CVS More Risky?
AirSculpt Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CVS Health has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.622%.
-
Which is a Better Dividend Stock AIRS or CVS?
AirSculpt Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health offers a yield of 3.93% to investors and pays a quarterly dividend of $0.67 per share. AirSculpt Technologies pays -3.05% of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AIRS or CVS?
AirSculpt Technologies quarterly revenues are $39.2M, which are smaller than CVS Health quarterly revenues of $97.7B. AirSculpt Technologies's net income of -$5M is lower than CVS Health's net income of $1.6B. Notably, AirSculpt Technologies's price-to-earnings ratio is 300.71x while CVS Health's PE ratio is 18.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies is 0.58x versus 0.23x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies0.58x 300.71x $39.2M -$5M CVSCVS Health0.23x 18.48x $97.7B $1.6B
-
Which has Higher Returns AIRS or FPCG?
First Physicians Capital Group has a net margin of -12.85% compared to AirSculpt Technologies's net margin of --. AirSculpt Technologies's return on equity of -9.96% beat First Physicians Capital Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies57.25% -$0.09 $154M FPCGFirst Physicians Capital Group-- -- -- -
What do Analysts Say About AIRS or FPCG?
AirSculpt Technologies has a consensus price target of $2.75, signalling upside risk potential of 52.78%. On the other hand First Physicians Capital Group has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies has higher upside potential than First Physicians Capital Group, analysts believe AirSculpt Technologies is more attractive than First Physicians Capital Group.
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies0 3 0 FPCGFirst Physicians Capital Group0 0 0 -
Is AIRS or FPCG More Risky?
AirSculpt Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Physicians Capital Group has a beta of -12.023, suggesting its less volatile than the S&P 500 by 1302.307%.
-
Which is a Better Dividend Stock AIRS or FPCG?
AirSculpt Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies pays -3.05% of its earnings as a dividend. First Physicians Capital Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AIRS or FPCG?
AirSculpt Technologies quarterly revenues are $39.2M, which are larger than First Physicians Capital Group quarterly revenues of --. AirSculpt Technologies's net income of -$5M is higher than First Physicians Capital Group's net income of --. Notably, AirSculpt Technologies's price-to-earnings ratio is 300.71x while First Physicians Capital Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies is 0.58x versus 1.40x for First Physicians Capital Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies0.58x 300.71x $39.2M -$5M FPCGFirst Physicians Capital Group1.40x -- -- --
-
Which has Higher Returns AIRS or IQV?
IQVIA Holdings has a net margin of -12.85% compared to AirSculpt Technologies's net margin of 11.04%. AirSculpt Technologies's return on equity of -9.96% beat IQVIA Holdings's return on equity of 21.32%.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies57.25% -$0.09 $154M IQVIQVIA Holdings34.82% $2.42 $20.1B -
What do Analysts Say About AIRS or IQV?
AirSculpt Technologies has a consensus price target of $2.75, signalling upside risk potential of 52.78%. On the other hand IQVIA Holdings has an analysts' consensus of $242.54 which suggests that it could grow by 67.86%. Given that IQVIA Holdings has higher upside potential than AirSculpt Technologies, analysts believe IQVIA Holdings is more attractive than AirSculpt Technologies.
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies0 3 0 IQVIQVIA Holdings15 5 0 -
Is AIRS or IQV More Risky?
AirSculpt Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison IQVIA Holdings has a beta of 1.459, suggesting its more volatile than the S&P 500 by 45.883%.
-
Which is a Better Dividend Stock AIRS or IQV?
AirSculpt Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies pays -3.05% of its earnings as a dividend. IQVIA Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AIRS or IQV?
AirSculpt Technologies quarterly revenues are $39.2M, which are smaller than IQVIA Holdings quarterly revenues of $4B. AirSculpt Technologies's net income of -$5M is lower than IQVIA Holdings's net income of $437M. Notably, AirSculpt Technologies's price-to-earnings ratio is 300.71x while IQVIA Holdings's PE ratio is 19.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies is 0.58x versus 1.72x for IQVIA Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies0.58x 300.71x $39.2M -$5M IQVIQVIA Holdings1.72x 19.27x $4B $437M
-
Which has Higher Returns AIRS or UNVC?
UNIVEC has a net margin of -12.85% compared to AirSculpt Technologies's net margin of --. AirSculpt Technologies's return on equity of -9.96% beat UNIVEC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies57.25% -$0.09 $154M UNVCUNIVEC-- -- -- -
What do Analysts Say About AIRS or UNVC?
AirSculpt Technologies has a consensus price target of $2.75, signalling upside risk potential of 52.78%. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies has higher upside potential than UNIVEC, analysts believe AirSculpt Technologies is more attractive than UNIVEC.
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies0 3 0 UNVCUNIVEC0 0 0 -
Is AIRS or UNVC More Risky?
AirSculpt Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UNIVEC has a beta of 0.149, suggesting its less volatile than the S&P 500 by 85.124%.
-
Which is a Better Dividend Stock AIRS or UNVC?
AirSculpt Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies pays -3.05% of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AIRS or UNVC?
AirSculpt Technologies quarterly revenues are $39.2M, which are larger than UNIVEC quarterly revenues of --. AirSculpt Technologies's net income of -$5M is higher than UNIVEC's net income of --. Notably, AirSculpt Technologies's price-to-earnings ratio is 300.71x while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies is 0.58x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies0.58x 300.71x $39.2M -$5M UNVCUNIVEC-- -- -- --
-
Which has Higher Returns AIRS or WORX?
SCWorx has a net margin of -12.85% compared to AirSculpt Technologies's net margin of -55.94%. AirSculpt Technologies's return on equity of -9.96% beat SCWorx's return on equity of -80.46%.
Company Gross Margin Earnings Per Share Invested Capital AIRSAirSculpt Technologies57.25% -$0.09 $154M WORXSCWorx17.45% -$0.27 $4.5M -
What do Analysts Say About AIRS or WORX?
AirSculpt Technologies has a consensus price target of $2.75, signalling upside risk potential of 52.78%. On the other hand SCWorx has an analysts' consensus of -- which suggests that it could fall by --. Given that AirSculpt Technologies has higher upside potential than SCWorx, analysts believe AirSculpt Technologies is more attractive than SCWorx.
Company Buy Ratings Hold Ratings Sell Ratings AIRSAirSculpt Technologies0 3 0 WORXSCWorx0 0 0 -
Is AIRS or WORX More Risky?
AirSculpt Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SCWorx has a beta of 3.403, suggesting its more volatile than the S&P 500 by 240.336%.
-
Which is a Better Dividend Stock AIRS or WORX?
AirSculpt Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AirSculpt Technologies pays -3.05% of its earnings as a dividend. SCWorx pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AIRS or WORX?
AirSculpt Technologies quarterly revenues are $39.2M, which are larger than SCWorx quarterly revenues of $759.7K. AirSculpt Technologies's net income of -$5M is lower than SCWorx's net income of -$425K. Notably, AirSculpt Technologies's price-to-earnings ratio is 300.71x while SCWorx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AirSculpt Technologies is 0.58x versus 0.39x for SCWorx. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AIRSAirSculpt Technologies0.58x 300.71x $39.2M -$5M WORXSCWorx0.39x -- $759.7K -$425K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How Bad Will the Stock Market Get?
In recent trading days, global stock markets have seen massive…
Is JOBY Stock a Buy, Sell or Hold?
Joby Aviation (NYSE:JOBY) got started with the big idea of…
Stock Ideas
Sell
36
Is MSFT Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 30x
Sell
30
Is AAPL Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 28x
Sell
33
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 33x
Alerts
Buy
55
SLNO alert for Apr 9
Soleno Therapeutics [SLNO] is up 6% over the past day.
Sell
20
HELE alert for Apr 9
Helen Of Troy [HELE] is up 8.22% over the past day.
Sell
18
OXM alert for Apr 9
Oxford Industries [OXM] is up 14.46% over the past day.
